Brief: Nanologica Board Recommends Not To Accept Cash Offer Made By Flerie Invest
Corrects name of source company June 13 (Reuters) - Nanologica NICA.ST: BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS NOT TO ACCEPT MANDATORY CASH OFFER MADE BY FLERIE AB FLERIE.ST BOARD SAYS OFFER DOES NOT REFLECT LONG-TERM POTENTIAL OR UNDERLYING VALUE OF COMPANY Source text: ID:nMFN78Tw6 Further company coverage: FLERIE.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen